Professional Role and Tenure
Lee Anne Howe has been serving as the Chief Information Officer (CIO) at Lantheus Medical Imaging, Inc. since August 2016. In addition to her CIO role, she holds the title of Vice President of IT and Enterprise Program Management Office (EPMO), indicating a senior leadership responsibility for both technology strategy and oversight of enterprise-wide program management initiatives. Her role includes overseeing Lantheus’ information and technology strategy as well as managing its EPMO, reflecting a strong influence on the company’s digital transformation and operational execution through technology.
Industry Experience and Expertise
Ms. Howe brings over 20 years of IT leadership experience predominantly in the life sciences and healthcare sectors, underlining deep domain expertise relevant to Lantheus’ focus on diagnostic imaging and radiopharmaceuticals. Before joining Lantheus, her experience included time at General Electric Co., suggesting exposure to large, complex organizations and possibly regulated industries. She is recognized as a results-driven IT leader with a track record of delivering business value through technology.
Education
Lee Anne Howe holds a Bachelor of Science degree in Finance and German from Penn State University, suggesting a foundation that combines business acumen with cross-cultural and communication skills.
Leadership Roles and Industry Recognition
- Chair of BostonCIO (2024 and 2025): Serving as Chair of this prestigious regional CIO leadership organization highlights her stature and influence within the Boston technology leadership community and the broader CIO ecosystem.
- 2018 BostonCIO ORBIE Award Winner in the Healthcare & Life Sciences category, a significant peer-recognized honor for excellence in CIO leadership.
- Vice Chair and Advisory Board Membership on BostonCIO, further emphasizing her active engagement in shaping regional IT leadership and best practices.
Location and Network
Ms. Howe is based in Stow, Massachusetts, and maintains an extensive professional network with 500+ LinkedIn connections, underscoring a well-established presence within her professional circles.
Contribution to Company Initiatives and Strategy
While specific project details at Lantheus are not publicly detailed, her leadership position as CIO and responsible oversight of the EPMO implies stewardship of critical enterprise programs including IT infrastructure, digital innovation, compliance systems, and support of Lantheus’ operations in diagnostic imaging and radiopharmaceutical markets.
Her role involves strategic alignment of technology with regulatory demands and product innovation, especially in a company like Lantheus which is engaged in ongoing expansion of its imaging agents portfolio and novel radiopharmaceuticals—e.g., recent approvals noted in 2024 involving FDA applications for imaging agents targeted at specific clinical needs.
Company Context and Recent Developments
Lantheus Holdings Inc. has been actively advancing its product pipeline and market presence, including:
- The July 2024 acquisition of global rights to Life Molecular’s clinical stage RM2, a gastrin-releasing peptide receptor (GRPR)-targeting agent for prostate cancer diagnostics and therapeutics.
- FDA approval in March 2024 for supplemental indications of DEFINITY, a key ultrasound contrast agent, expanding its pediatric application.
These product initiatives suggest ongoing IT demands for data management, regulatory compliance, clinical trial support, and market analytics—areas likely influenced under Howe's IT leadership.
Summary of Ratings and Public Perceptions
On the employee feedback platform Comparably, Lee Howe holds a rating of 3.2 out of 5 based on 167 ratings, indicating mixed public perception from current or former employees, although no further contextual details are available for interpretation.
This profile establishes Lee Anne Howe as a veteran IT and program management executive with deep life sciences experience, a recognized leader within the regional CIO community, and a key architect of Lantheus’ digital and operational infrastructure aligned with its clinical and commercial goals. Her leadership role places her at the intersection of technology, regulatory compliance, and strategic growth initiatives, making her central to Lantheus' continued innovation and market advancement in molecular imaging and diagnostic products.
